Fibrin Sealants Market Report 2026

Fibrin Sealants Market Overview

• Fibrin Sealants market size has reached to $1.17 billion in 2025 • Expected to grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Rising Demand For Cosmetic Surgeries Fuels Growth In The Fibrin Sealants Market • Market Trend: Advancements In Fibrin Sealant Solutions For Improved Surgical Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Fibrin Sealants Market?

Fibrin sealants, also known as fibrin glues or fibrin tissue adhesives, are specialized medical products used to promote blood clotting and tissue healing. They are composed of two main components derived from human or animal blood, fibrinogen (a protein involved in blood clot formation) and thrombin (an enzyme that converts fibrinogen into fibrin, the main substance in blood clots). Fibrin sealants are commonly used during surgeries to control bleeding, especially in delicate or hard-to-reach areas where traditional sutures or cauterization may be insufficient. The main types in the fibrin sealants market are liquid, patch, and powder. Liquid fibrin sealants are solutions containing fibrinogen and thrombin that, when mixed, form a fibrin clot. These products are used during surgical procedures to control bleeding and promote tissue adhesion. They can be applied through various methods, such as dripping or spraying, enabling precise delivery to the bleeding site. The technologies involved are autologous donation, viral inactivation, recombinant production, and others. The applications of fibrin sealants are for span general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgeries, ophthalmic surgeries, transplant surgery, and others, and are used by hospitals, ambulatory surgical centers, and other healthcare facilities.

What Is The Fibrin Sealants Market Growth Forecast?

The fibrin sealants market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to advancements in recombinant fibrin production, growth in minimally invasive and robotic surgeries, increasing demand in cardiovascular and orthopedic procedures, rising regulatory approvals and quality certifications, development of bioabsorbable and multifunctional sealants. Major trends in the forecast period include rising adoption of fibrin sealants in minimally invasive surgeries, increasing use of recombinant and synthetic sealants, expansion of orthopedic and cardiovascular surgeries, growing focus on blood conservation and hemostasis, rising preference for bioabsorbable and patch-based sealants.

Global Fibrin Sealants Market Segmentation

1) By Type: Liquid, Patch, Powder 2) By Technology: Autologous Donation, Viral Inactivation, Recombinant Production, Other Technologies 3) By Application: General Surgery, Cardiovascular Surgery, Wound Management, Orthopedic Surgery, Urological Surgeries, Ophthalmic Surgeries, Transplant Surgery, Other Applications 4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Liquid: Bovine-Derived Liquid Sealants, Human-Derived Liquid Sealants, Synthetic Liquid Sealants, Recombinant Fibrin Sealants 2) By Patch: Bovine-Derived Fibrin Patches, Human-Derived Fibrin Patches, Synthetic Fibrin Patches, Bioabsorbable Fibrin Patches 3) By Powder: Bovine-Derived Fibrin Powder, Human-Derived Fibrin Powder, Synthetic Fibrin Powder, Recombinant Fibrin Powder

What Is The Driver Of The Fibrin Sealants Market?

The increasing number of cosmetic surgeries is expected to propel the growth of the fibrin sealants market going forward. Cosmetic surgeries refer to medical procedures that are primarily focused on enhancing or altering a person's appearance. Cosmetic surgeries are rising due to societal emphasis on appearance, advancements in surgical techniques, and the growing accessibility of minimally invasive procedures. Fibrin sealants help in cosmetic surgeries, promote faster wound healing, reduce bleeding, and minimize scarring, enhancing surgical outcomes and patient recovery. For instance, in September 2023, according to CosmetAssure, a US-based American Society of Plastic Surgeons, liposuction remained the most in-demand plastic surgery procedure in 2023, with 347,782 procedures performed, a 7% increase from 2022, and tummy tucks also saw a 5% rise, with 170,110 procedures performed. Therefore, the increasing number of cosmetic surgeries drives the fibrin sealants industry.

Key Players In The Global Fibrin Sealants Market

Major companies operating in the fibrin sealants market are Johnson & Johnson, Takeda Pharmaceutical Company Limited, Asahi Kasei Medical Co. Ltd., Baxter International Inc., CSL Behring, Grifols S.A., Sigma-Aldrich, Nordson Corporation, Integra LifeSciences Corporation, Shanghai RAAS Blood Products Co. Ltd., Mallinckrodt Pharmaceuticals, Biotest AG, LFB Group, Hualan Biological Engineering Inc., Corza Medical, Aesculap Inc., Ethicon Inc., CryoLife Inc., VIVEX Biologics Inc., MediWound Ltd., Cohesion Technologies Inc

Global Fibrin Sealants Market Trends and Insights

Major companies operating in the Fibrin Sealants market are focusing on developing innovative solutions, such as fibrin sealant, to enhance hemostasis, reduce surgical complications, improve wound healing outcomes, and optimize patient recovery across various surgical procedures. Fibrin sealants, also known as fibrin glues, are biological adhesive products derived from human or animal blood components that mimic the final stages of the natural blood clotting process. For instance, in October 2024, Grifols S.A., a Spain-based global biopharmaceutical company, received FDA approval for its fibrin sealant solution to treat surgical bleeding in pediatric patients. This product is designed to enhance surgical safety, improve clot formation at the wound site, and reduce the risk of postoperative complications, offering a specialized option for pediatric surgeries where precise hemostasis is critical. The solution can be used across various surgical settings, providing versatility and efficiency compared to conventional approaches.

What Are Latest Mergers And Acquisitions In The Fibrin Sealants Market?

In July 2024, Corza Medical, a US-based manufacturer of innovative surgical technologies, acquired Takeda’s TachoSil Manufacturing Operations located in Linz, Austria for an undisclosed amount. The acquisition allows Corza Medical to directly control manufacturing priorities, which is expected to enhance service levels and support customers globally. Takeda is a Japan-based pharmaceutical company, involved in the development and manufacturing of fibrin sealants.

Regional Outlook

North America was the largest region in the fibrin sealants market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Fibrin Sealants Market?

The fibrin sealants market consists of sales of hemostatic agents, surgical sealants, tissue adhesives, and wound care products. Values in this market are ‘factory gate’ values, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.